98 related articles for article (PubMed ID: 10776752)
1. Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma.
Chatterjee R; Kottaridis PD; Lees WR; Ralph DJ; Goldstone AH
Lancet; 2000 Apr; 355(9212):1335-6. PubMed ID: 10776752
[TBL] [Abstract][Full Text] [Related]
2. Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies.
Chatterjee R; Andrews HO; McGarrigle HH; Kottaridis PD; Lees WR; Mackinnon S; Ralph DJ; Goldstone AH
Bone Marrow Transplant; 2000 Jun; 25(11):1185-9. PubMed ID: 10849531
[TBL] [Abstract][Full Text] [Related]
3. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
4. Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft.
Fermand JP; Lévy Y; Gerota J; Benbunan M; Cosset JM; Castaigne S; Seligmann M; Brouet JC
Nouv Rev Fr Hematol (1978); 1989; 31(2):85-7. PubMed ID: 2570400
[TBL] [Abstract][Full Text] [Related]
5. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
[TBL] [Abstract][Full Text] [Related]
6. Marrow transplantation for myeloma.
Fermand JP; Brouet JC
Annu Rev Med; 1995; 46():299-307. PubMed ID: 7598466
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Lonial S; Kaufman J; Tighiouart M; Nooka A; Langston AA; Heffner LT; Torre C; McMillan S; Renfroe H; Harvey RD; Lechowicz MJ; Khoury HJ; Flowers CR; Waller EK
Clin Cancer Res; 2010 Oct; 16(20):5079-86. PubMed ID: 20739431
[TBL] [Abstract][Full Text] [Related]
8. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes.
Chen CI; Abraham R; Tsang R; Crump M; Keating A; Stewart AK
Bone Marrow Transplant; 2001 Jan; 27(2):177-82. PubMed ID: 11281387
[TBL] [Abstract][Full Text] [Related]
9. Fatal progressive systemic sclerosis following autologous stem cell transplantation and high-dose chemotherapy.
Trad S; Amoura Z; Haroche J; Huong Du Boutin LT; Wechsler B; Leblond V; Piette JC
Rheumatology (Oxford); 2005 Jul; 44(7):951-3. PubMed ID: 15814574
[No Abstract] [Full Text] [Related]
10. Transplantation in multiple myeloma.
Topolsky D; Biggs D
Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
[No Abstract] [Full Text] [Related]
11. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
12. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
13. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
14. [Multiple myeloma: past, present and future].
Zulian GB
Rev Med Suisse Romande; 1989 Nov; 109(11):939-45. PubMed ID: 2688027
[No Abstract] [Full Text] [Related]
15. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
[TBL] [Abstract][Full Text] [Related]
16. [High dosage chemotherapy with autologous stem cell transplantation in multiple myeloma].
Ruckser R; Kier P; Buxhofer V; Kittl E; Tatzreiter G; Vedovelli H; Zelenka P; Hübl G; Hinterberger W
Acta Med Austriaca Suppl; 2000; 52():40-2. PubMed ID: 11261278
[TBL] [Abstract][Full Text] [Related]
17. Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantation.
Chatterjee R; Palla K; Kottaridis PD
J Clin Oncol; 2004 Jun; 22(11):2253-4. PubMed ID: 15169819
[No Abstract] [Full Text] [Related]
18. High-dose chemotherapy in multiple myeloma.
Goldschmidt H; Hegenbart U; Wallmeier M; Moos M; Haas R
Leukemia; 1997 Dec; 11 Suppl 5():S27-31. PubMed ID: 9436935
[TBL] [Abstract][Full Text] [Related]
19. Meningeal hematopoiesis following radiation myelitis in a hematopoietic stem-cell transplant recipient.
Sakai M; Ohashi K; Kobayashi T; Yamashita T; Akiyama H; Nemoto T; Kishida S; Kamata N; Sakamaki H
Am J Hematol; 2005 Aug; 79(4):291-3. PubMed ID: 16044440
[TBL] [Abstract][Full Text] [Related]
20. [Multiple myeloma in 1990].
Le Loët X; Monconduit M; Euller-Ziegler L
Ann Med Interne (Paris); 1990; 141(2):108-10. PubMed ID: 2191611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
